8% L-Arginine/Calcium Carbonate Toothpaste in Comparison to Strontium Acetate Toothpaste for Hypersensitive Dentin

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03068533
Collaborator
(none)
46
1
2
3
15.6

Study Details

Study Description

Brief Summary

Dentinal hypersensitivity [DH] is a common condition in daily practice, especially in patients who have abrasion, attrition, gingival recession and erosion of teeth. It can affect individuals in the age range of 20-50 years.In a recent systematic review, it was reported that no gold standard treatment modality for dentin hypersensitivity has been established Thus there is a need to evaluate new formulations in different settings and in different populations and to compare those to commonly used agents seeking better results in pain relief for our patients. Studies showed that dentifrice formulations containing 8% arginine in combination with calcium carbonate and fluoride have the ability to plug dentinal tubules, by clumping of both arginine and calcium carbonate that bind with the negatively charged dentin . Aim of the study is to clinically evaluate toothpaste containing 8% arginine, calcium carbonate, and sodium mono-fluorophosphate, in comparison to toothpaste, containing 8% strontium acetate and NaF on the relief of DH in chronic periodontitis patients.

Condition or Disease Intervention/Treatment Phase
  • Other: 8% L-Arginine/calcium carbonate containing toothpaste
  • Other: use of strontium acetate toothpaste
N/A

Detailed Description

  1. Each eligible patient will be given a number.

  2. All eligible patients will receive mechanical debridement in 1 or 2 sessions within 1 week before final evaluation.

  3. The hypersensitive teeth will be isolated with cotton rolls, and stimuli will be applied to each tooth for final evaluation after scaling and debridement.

  4. Air Sensitivity scale is used to assess sensitivity to air blast, while cold water test and tactile test will be held and assessed by Visual Analog Scale (VAS) , which score from 0 (no pain) to 10 (intense pain).

  5. Patients will be handed a 30ml. white package written on it the previously assigned number to them and instructed to brush twice daily with the assigned toothpaste by a soft-bristled toothbrush for 8 weeks, with several returns to the clinic for re-evaluation and to take the refill of the assigned number of toothpaste.

  6. Air blast sensitivity score and VAS will be evaluated again weekly and till the end of the evaluation period.

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
similar empty tubes filled by the control and intervention toothpaste then sealed and given a number only.The patients,care provider,outcome assessor and investigator are blinded to the intervention and control toothpaste.
Primary Purpose:
Treatment
Official Title:
The Use of 8% L-Arginine/Calcium Carbonate Containing Toothpaste in Comparison to Strontium Acetate Containing Toothpaste in Management of Hypersensitive Dentine in Chronic Periodontitis Patients : A Randomized-controlled Clinical Trial
Actual Study Start Date :
Jan 1, 2018
Anticipated Primary Completion Date :
Mar 3, 2018
Anticipated Study Completion Date :
Apr 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Strontium acetate toothpaste

All eligible patients will receive mechanical debridement in 1 or 2 sessions within 1 week before final evaluation.

Other: use of strontium acetate toothpaste
use of strontium acetate toothpaste to relieve hypersensitivity

Experimental: Arginine/calcium carbonate toothpaste

All eligible patients will receive mechanical debridement in 1 or 2 sessions within 1 week before final evaluation.

Other: 8% L-Arginine/calcium carbonate containing toothpaste
use of 8% L-Arginine/calcium carbonate containing toothpaste to relieve hypersensitivity

Outcome Measures

Primary Outcome Measures

  1. change from baseline Pain (sensetivity) at 8 weeks [baseline and after 8 weeks]

    This will be assessed using VAS that will be determined immediately before product use and then after 8 weeks of daily brushing with the test and control toothpastes following stimulus application using Visual Analog Scale (VAS)

Secondary Outcome Measures

  1. Probing pocket depth [baseline and after 8 weeks]

    probing depth from gingival margin and till base of the pocket or sulcus in mm.

  2. Gingival recession (GR) [baseline and after 8 weeks]

    if present, distance between gingival margin to cemento-enamel junction in mm.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Slight to moderate chronic periodontitis patients diagnosed according to criteria of (Parameter on chronic periodontitis with slight to moderate loss of periodontal support.

American Academy of Periodontology., 2000) as follows : Probing pocket depths up to 6mm Clinical attachment loss (CAL) up to 4mm Class I (incipient) furcation involvement Radiographic evidence of bone loss.

  1. At least 2 teeth presenting hypersensitive areas on facial surfaces of teeth with score 2 or 3 on the air sensitivity scale (Pepelassi et al., 2015)

  2. Provision of written informed consent

Exclusion Criteria:
  1. Chipped teeth.

  2. Defective restorations.

  3. Deep dental caries or large restorations showing pulpal response.

  4. Ongoing treatment with anti-inflammatory drugs.

  5. Ongoing treatment for tooth hypersensitivity.

  6. Pregnancy.

  7. Uncontrolled metabolic diseases.

  8. Psychiatric disorder.

  9. Smoking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo University Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Prof.Dr. Manal Hosni, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abdallah Hassan Mostafa, DR. Abdallah Hassan, Cairo University
ClinicalTrials.gov Identifier:
NCT03068533
Other Study ID Numbers:
  • Abdallah Hassan
First Posted:
Mar 3, 2017
Last Update Posted:
Feb 14, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Abdallah Hassan Mostafa, DR. Abdallah Hassan, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2018